n-methylaspartate has been researched along with Movement Disorders in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ayuso-Dolado, S; Díaz-Guerra, M; Esteban-Ortega, GM; Vidaurre, ÓG | 1 |
| Almenares, JL; Blanco-Lezcano, L; Díaz-Hung, ML; Francis-Turner, L; González-Fraguela, ME; Jimenez-Martin, J; Serrano-Sánchez, T | 1 |
| Cross, AH; Goldberg, MP; Gonzales, E; Pitt, D | 1 |
| Bhatia, K; Edwards, MJ; Teo, JT | 1 |
| Kim, YH; Koh, JY; Yi, JS | 1 |
| Beffert, U; Bock, HH; Herz, J; Marth, JD; May, P; Noebels, JL; Rohlmann, A; Schomburg, ED; Sweatt, JD; Weeber, EJ; Zurhove, K | 1 |
1 review(s) available for n-methylaspartate and Movement Disorders
| Article | Year |
|---|---|
Tardive dyskinesia is caused by maladaptive synaptic plasticity: a hypothesis.
Topics: Adaptation, Physiological; Antipsychotic Agents; Corpus Striatum; Excitatory Amino Acid Agents; gamma-Aminobutyric Acid; Humans; Movement Disorders; N-Methylaspartate; Neuronal Plasticity; Oxidative Stress; Synapses | 2012 |
5 other study(ies) available for n-methylaspartate and Movement Disorders
| Article | Year |
|---|---|
A novel cell-penetrating peptide targeting calpain-cleavage of PSD-95 induced by excitotoxicity improves neurological outcome after stroke.
Topics: Animals; Brain Ischemia; Calpain; Cell Survival; Cell-Penetrating Peptides; Cells, Cultured; Disease Models, Animal; Disks Large Homolog 4 Protein; Down-Regulation; Excitatory Amino Acid Agonists; HEK293 Cells; Humans; Male; Mice; Mice, Inbred BALB C; Movement Disorders; N-Methylaspartate; Neurons; Neuroprotection; Stroke | 2021 |
Effect of neurotoxic lesion of pedunculopontine nucleus in nigral and striatal redox balance and motor performance in rats.
Topics: Animals; Catalase; Corpus Striatum; Excitatory Amino Acid Agonists; Forelimb; Functional Laterality; Male; Malondialdehyde; Motor Activity; Movement Disorders; N-Methylaspartate; Nitric Oxide; Oxidation-Reduction; Oxidative Stress; Pedunculopontine Tegmental Nucleus; Postural Balance; Rats, Wistar; Substantia Nigra | 2015 |
Dysmyelinated axons in shiverer mice are highly vulnerable to alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor-mediated toxicity.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Biomarkers; Brain; Disease Models, Animal; Excitatory Amino Acid Agonists; Female; Hereditary Central Nervous System Demyelinating Diseases; Luminescent Proteins; Mice; Mice, Inbred C57BL; Mice, Neurologic Mutants; Movement Disorders; Myelin Basic Protein; N-Methylaspartate; Nerve Degeneration; Nerve Fibers, Myelinated; Neurotoxins; Receptors, AMPA | 2010 |
Infarct reduction in rats following intraventricular administration of either tissue plasminogen activator (tPA) or its non-protease mutant S478A-tPA.
Topics: Animals; Brain; Brain Infarction; Brain Ischemia; Cells, Cultured; Coculture Techniques; Disease Models, Animal; Endopeptidases; Fetus; Infarction, Middle Cerebral Artery; Injections, Intraventricular; Male; Mice; Movement Disorders; Mutation; N-Methylaspartate; Protein Conformation; Rats; Rats, Sprague-Dawley; Tissue Plasminogen Activator; Treatment Outcome; Zinc | 2004 |
Neuronal LRP1 functionally associates with postsynaptic proteins and is required for normal motor function in mice.
Topics: Animals; Behavior, Animal; Brain; Cells, Cultured; Coculture Techniques; Disks Large Homolog 4 Protein; Dopamine; Electroencephalography; Electromyography; Excitatory Amino Acid Agonists; Guanylate Kinases; Intracellular Signaling Peptides and Proteins; Long-Term Potentiation; Low Density Lipoprotein Receptor-Related Protein-1; Membrane Proteins; Mice; Mice, Knockout; Mice, Transgenic; Motor Activity; Movement Disorders; N-Methylaspartate; Nerve Tissue Proteins; Neurons; Protein Subunits; Rats; Receptors, LDL; Receptors, N-Methyl-D-Aspartate; Synapses; Synapsins; Synaptic Transmission; Tissue Distribution; Tumor Suppressor Proteins | 2004 |